News for Life Sciences sector
MMV releases its IPortfolio nvestment and Highlights for the First Quarter of 2011
>>
TARGETING LRP-1 TO CREATE BREAKTHROUGH DRUGS THAT CROSS THE BBB
Geron expands clinical oncology pipeline with license and collabo...
>>
CHARLOTTE, NC. July 29, 2009 - US HIFU, LLC, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies, has secured a $5 million&...
>>
Bedford, Massachusetts and Toronto, Ontario – EM4 Inc., a premier U.S. manufacturer of optoelectronic components for the U.S. industrial and defense industries, today announced the completion of US $2...
>>
FOR IMMEDIATE RELEASE
Montreal, Quebec – December 20, 2007 – AngioChem Inc. (“AngioChem”) a Montreal-based biotechnology company dedicated to creating and developing novel therapies to treat brain d...
>>
EWING, NJ, Business Wire/ -- Antares Pharma, Inc. (Amex: AIS) announced today that is has closed on a secured credit facility consisting of two term loans in the aggregate principal amount of US$10,00...
>>
Montreal, Quebec and Toronto, Ontario– January 30, 2007 – Osprey Pharmaceuticals Limited, a privately held biotechnology company focused on treating chronic diseases through a family of first-in-class...
>>
Toronto, Ontario – January 22, 2007 – Xceed Molecular Corporation (“Xceed”), a developer of an innovative platform for multiplexed, gene-expression based molecular diagnostics, announces that it has s...
>>
Mistral Pharma Inc. (TSX Venture Exchange: MIP) (“Mistral”) announces today that it has secured a US$1.5 million debt financing from MMV Financial Inc. (“MMV”). In connection with the loan, Mistral is...
>>
Tuesday, October 10, 2006
TORONTO, CANADA – Insception Biosciences Inc., Canada’s leading cord blood bank, is pleased to announce the closing of a US$2.75MM venture financing from MMV Financial In...
>>